News

Under the terms of the agreement, Sosei will be responsible for development and registration and Aska for sales and marketing. A joint committee will be established to oversee

Under the five-year contract, Trius will develop novel drugs targeting bacterial DNA gyrase and topoisomerase IV, with the aim of optimizing these drugs for activity against relevant biodefense

The data showed that Humira provided long-term treatment of fistulas, with more than half of patients with moderate to severe Crohn’s disease experiencing fistula healing at three years.

Nuo Hua is a holding company with subsidiaries and affiliated companies that maintain a significant presence in pharmaceutical wholesale and retail distribution in China. American Oriental Bioengineering (AOBO)

This 12-week, four-arm, parallel group Phase II clinical trial will enroll 200 patients and is designed to provide a head-to-head comparison of the efficacy and tolerability of 0.25mg,

The minister’s approval is the culmination of a thorough regulatory process under the Medicines Act 1981, involving detailed consideration of clinical and ethical issues by a wide range

Dr Anik, the former president of pharmaceutical development services (PDS) at Patheon will lead Althea’s expansion of its product development, clinical trial and commercial manufacturing services. Magda Marquet

The company reported that 1,000 study participants have now been screened and entered into the study which includes a skin test, ArteFill injections and follow-up evaluations for safety

This patent protects important intermediates in Alchemia’s synthetic process and provides Alchemia with the legal means to prevent other companies from using these intermediates, or selling product derived